Literature DB >> 9135222

Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis.

W Hui1, M Bell, G Carroll.   

Abstract

OBJECTIVE: To measure oncostatin M (OSM) in synovial fluid from patients with rheumatoid arthritis (RA) and osteoarthritis (OA).
METHODS: 20 samples of synovial fluid from patients with RA and 10 samples from patients with OA were examined using an OSM specific sandwich ELISA.
RESULTS: OSM was detected at concentrations ranging from 2.36 to 901.82 pg/ml in 18 (90%) of 20 samples of synovial fluid from RA patients. There was no detectable OSM in synovial fluid from OA patients. In the RA patients, the OSM concentration in synovial fluid correlated significantly with the synovial fluid white blood cell count (r = 0.67, p < 0.01), but not with other laboratory parameters of disease activity.
CONCLUSION: These findings suggest that OSM may contribute to joint inflammation in RA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135222      PMCID: PMC1752333          DOI: 10.1136/ard.56.3.184

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.

Authors:  Carrie M Elks; Peng Zhao; Ryan W Grant; Hardy Hang; Jennifer L Bailey; David H Burk; Margaret A McNulty; Randall L Mynatt; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

2.  Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.

Authors:  Randall E Ryan; Bryan Martin; Liliana Mellor; Reed B Jacob; Ken Tawara; Owen M McDougal; Julia Thom Oxford; Cheryl L Jorcyk
Journal:  Cytokine       Date:  2015-01-23       Impact factor: 3.861

Review 3.  gp130 at the nexus of inflammation, autoimmunity, and cancer.

Authors:  J S Silver; C A Hunter
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

4.  Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

5.  Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.

Authors:  David Sanchez-Infantes; Ursula A White; Carrie M Elks; Ron F Morrison; Jeffrey M Gimble; Robert V Considine; Anthony W Ferrante; Eric Ravussin; Jacqueline M Stephens
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

6.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.

Authors:  Andrew D Rowan; Wang Hui; Tim E Cawston; Carl D Richards
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

7.  Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptor.

Authors:  Johannes Drechsler; Joachim Grötzinger; Heike M Hermanns
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

8.  Oncostatin M induces heat hypersensitivity by gp130-dependent sensitization of TRPV1 in sensory neurons.

Authors:  Michiel Langeslag; Cristina E Constantin; Manfred Andratsch; Serena Quarta; Norbert Mair; Michaela Kress
Journal:  Mol Pain       Date:  2011-12-23       Impact factor: 3.395

9.  CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.

Authors:  Kiyoshi Migita; Atsumasa Komori; Takafumi Torigoshi; Yumi Maeda; Yasumori Izumi; Yuka Jiuchi; Taiichiro Miyashita; Minoru Nakamura; Satoru Motokawa; Hiromi Ishibashi
Journal:  Arthritis Res Ther       Date:  2011-05-06       Impact factor: 5.156

10.  Oncostatin M Confers Neuroprotection against Ischemic Stroke.

Authors:  Sen Guo; Zuo-Zhi Li; Jun Gong; Mei Xiang; Peng Zhang; Guang-Nian Zhao; Mingchang Li; Ankang Zheng; Xueyong Zhu; Hao Lei; Tanaka Minoru; Hongliang Li
Journal:  J Neurosci       Date:  2015-08-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.